Technology

Explore our proprietary Small Mobile Stem (SMS) cell technology

Review our pre-clinical proof-of-concept and safety studies

Track our groundbreaking Phase I clinical trial targeting COPD.

Discover our latest breakthroughs, company news, and milestones

Learn about our mission to revolutionize regenerative medicine

Meet the team of leading researchers, business executives, and expert advisors

We’re always looking for talented people. Join our team!

Explore investment opportunities and learn about our proprietary technology

SMSbiotech Appoints Michael C. Swartzburg as Chief Financial Officer

SMSbiotech Appoints Michael C. Swartzburg as Chief Financial Officer

Technology

Explore our proprietary Small Mobile Stem (SMS) cell technology

Review our pre-clinical proof-of-concept and safety studies

Track our groundbreaking Phase I clinical trial targeting COPD.

CPHI Middle East & BIO Middle East 2026

December 14, 2026

Subscribe for updates

Thank you! We received your submission!

Oops! Something went wrong

Science

The Science Animal Studies Human Studies News & Updates

Company

About Us Leadership Careers

Pipeline

Contact Us

Contact Terms & Conditions of Sales Terms of Use

© 2026 SMSbiotech All rights reserved. The information regarding the investigational product is for educational purposes only.